The TigerMed-backed neural diagnostics technology developer has topped up its coffers in a round co-led by Alpha Edison and Reimagined Ventures.

NovaSignal, a US-based brain diagnostics technology developer backed by clinical research services provider TigerMed, secured $37m in a series C1 round on Tuesday.

The round was co-led by venture capital firms Alpha Edison and Reimagined Ventures. It came after Alpha Edison led a $22m series C round for the company in May 2019 while it was still called Neural Analytics, having also issued warrants to buy stock in connection with the financing.

Founded in 2013, NovaSignal has created technology…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn